Dow Jones

39,512.84

0.32%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
BioPlus Acquisition Corporation (BIOS)
BioPlus Acquisition Corporation (BIOS) Noticias

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BIOS

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
04/10/2023	06:30	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate	NASDAQ:BIOS	BioPlus Acquisition Corporation
04/10/2023	06:30	GlobeNewswire Inc.	Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination	NASDAQ:BIOS	BioPlus Acquisition Corporation
16/08/2023	07:30	GlobeNewswire Inc.	Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring	NASDAQ:BIOS	BioPlus Acquisition Corporation
17/07/2023	07:00	GlobeNewswire Inc.	Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors	NASDAQ:BIOS	BioPlus Acquisition Corporation
14/06/2023	05:09	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOS	BioPlus Acquisition Corporation
14/06/2023	05:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOS	BioPlus Acquisition Corporation
13/06/2023	07:30	GlobeNewswire Inc.	Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando	NASDAQ:BIOS	BioPlus Acquisition Corporation
15/05/2023	15:29	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOS	BioPlus Acquisition Corporation
15/05/2023	05:38	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:BIOS	BioPlus Acquisition Corporation
12/05/2023	15:17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIOS	BioPlus Acquisition Corporation
03/05/2023	07:30	GlobeNewswire Inc.	Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation	NASDAQ:BIOS	BioPlus Acquisition Corporation
27/04/2023	15:35	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:BIOS	BioPlus Acquisition Corporation
14/02/2023	14:39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/02/2023	09:10	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BIOS	BioPlus Acquisition Corporation
11/03/2022	15:05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BIOS	BioPlus Acquisition Corporation
06/12/2021	07:00	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering	NASDAQ:BIOS	BioPlus Acquisition Corporation
03/02/2020	07:30	GlobeNewswire Inc.	Option Care Health Completes Reverse Stock Split and Ticker Symbol Change	NASDAQ:BIOS	BioPlus Acquisition Corporation
26/12/2019	15:24	GlobeNewswire Inc.	RLH Corporation Appoints R. Carter Pate as Chairman	NASDAQ:BIOS	BioPlus Acquisition Corporation
18/12/2019	08:22	GlobeNewswire Inc.	Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare Conference	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/12/2019	07:00	GlobeNewswire Inc.	Daniel E. Greenleaf Appointed as Chief Executive Officer of The Providence Service Corporation and LogistiCare	NASDAQ:BIOS	BioPlus Acquisition Corporation
21/11/2019	09:39	GlobeNewswire Inc.	Option Care Health to Participate in the Bank of America Merrill Lynch 2019 Leveraged Finance Conference	NASDAQ:BIOS	BioPlus Acquisition Corporation
19/11/2019	13:14	GlobeNewswire Inc.	Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment	NASDAQ:BIOS	BioPlus Acquisition Corporation
06/11/2019	05:00	GlobeNewswire Inc.	Option Care Health Announces Third Quarter Results	NASDAQ:BIOS	BioPlus Acquisition Corporation
16/10/2019	15:05	GlobeNewswire Inc.	Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call	NASDAQ:BIOS	BioPlus Acquisition Corporation
29/08/2019	17:05	Business Wire	Option Care Health to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference	NASDAQ:BIOS	BioPlus Acquisition Corporation
28/08/2019	16:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BIOS	BioPlus Acquisition Corporation
27/08/2019	15:01	GlobeNewswire Inc.	Kathryn Stalmack appointed as SVP, General Counsel and Corporate Secretary of Providence Service Corporation and LogistiCare	NASDAQ:BIOS	BioPlus Acquisition Corporation
13/08/2019	16:00	Business Wire	Option Care Health Receives Anticipated Nasdaq Notice	NASDAQ:BIOS	BioPlus Acquisition Corporation
08/08/2019	16:24	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:BIOS	BioPlus Acquisition Corporation
07/08/2019	17:58	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:BIOS	BioPlus Acquisition Corporation